Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study.

Michot, Jean-Marie

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study. [electronic resource] - American journal of hematology Mar 2015 - 197-203 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1096-8652

10.1002/ajh.23889 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Antiviral Agents--therapeutic use
Cryoglobulinemia--physiopathology
Female
Hepatitis C--complications
Humans
Lymphoma, B-Cell, Marginal Zone--complications
Lymphoma, Large B-Cell, Diffuse--complications
Male
Middle Aged
Rheumatoid Factor--blood
Survival Analysis
Treatment Outcome